X chromosome inactivation and polymorphism of the human androgen receptor (HUMARA) gene has been applied for analyzing the clonality of blood cells. In the present study, the clonal relationship was investigated between peripheral blood polymorphonuclear cells (PMNCs) and marrow progenitor cells and the origin of ringed sideroblasts in patients with refractory anemia with ring sideroblasts (RARS) by polymerase chain reaction (PCR) of HUMARA gene. The X-inactivation patterns of circulating PMNCs and T lymphocytes as well as individual granulocyte colonies grown in vitro from bone marrow cells were analyzed. The development of ringed sideroblasts in erythroid colonies by iron staining and their X-inactivation pattern were also examined. All three RARS patients showed monoclonal PMNCs. In granulocyte colonies, however, two different X-inactivation patterns were observed in all patients, indicating that non-clonal progenitor cells remained in the bone marrow. All erythroid colonies consisted of ringed sideroblasts exclusively showed one pattern dominant in those of PMNCs. Our findings suggest that non-clonal progenitor cells persist in some RARS cases, that erythroid progenitors show mosaicism, and that ringed sideroblasts may be derived from an abnormal clone involved in the pathogenesis of this disease.
Introduction
In patients with clonal hematopoiesis, the majority of circulating blood cells are derived from a single pluripotent stem cell that has gained a growth advantage. This condition is observed in myelodysplastic syndromes (MDS), [1] [2] [3] paroxysmal nocturnal hemoglobinuria (PNH), 4 and myeloproliferative disorders (MPD) 5, 6 including chronic myeloid leukemia (CML). 7, 8 The clonal nature of these hematological disorders has been analyzed using mainly peripheral blood samples. To understand the mechanism underlying clonal hematopoiesis, however, investigators need to know the clonality of hematopoietic progenitor cells in bone marrow as well as peripheral blood cells. The polymerase chain reaction (PCR) is a powerful tool for examining the clonality of small cell populations, such as individual hematopoietic colonies. Asano et al 9 have examined the clonal constitutions of progenitor cells in patients with MDS by the PCR-based X-chromosome inactivation analysis of the phosphoglycerate kinase (PGK) gene, and indicated that nonclonal hematopoietic progenitor cells can persist in the bone marrow in a substantial number of MDS patients.
The PGK-PCR analysis is applicable only for 33% of females, 10 and heteroduplex formation during the DNA ampli-fication makes it difficult to quantitate the clonal composition from the bands obtained. 11 Recently, PCR-based X-chromosome inactivation analysis of human androgen receptor (HUMARA) gene has been developed, 12, 13 and clonality studies of peripheral blood and hematopoietic colonies in patients with AA and MDS have been performed. 14 Compared to PGK gene,HUMARA has several advantages, eg high heterozygosity rate (approximately 90%) and no need for a second endonuclease digestion. 12 However, radioactivity may have limited usefulness and might have complex band patterns using denaturing gels and shadow band formation. 15 In this study, a rather unique method of the PCR-based clonal assay of HUM-ARA was used to enable the quantitation of the clonal constitution of examined cells without using radioactivity.
Refractory anemia with ring sideroblasts (RARS) or primary acquired sideroblastic anemia (PASA) is included in MDS and is characterized by the presence of ringed sideroblasts (RS) accounting for more than 15% of all nucleated cells in the bone marrow. 16 The clonal erythropoiesis in RARS was first suspected from dimorphism of red blood cells, consisting of hypochromic and normochromic cells. 17, 18 After that the clonal nature of RARS was analyzed, mainly on the basis of cytogenetic analyses. The results revealed that RARS is a clonal disorder, as in other types of myelodysplastic syndromes. 19 Prchal et al 20 studied the glucose-6-phosphate dehydrogenase (G6PD) isoenzymes and indicated the clonal cell growth in each lineage of mature blood cells in a female PASA patient heterozygous for the G6PD locus. Amenomori et al 21 demonstrated the clonal growth of sideroblasts and mosaicism of PASA clone and normal clone by cytogenetic or cytochemical analyses of individual hematopoietic colonies, but they did not compare the cytogenetical findings and cytochemical analysis of RS simultaneously in the same patients.
We analyzed clonal constitutions of peripheral blood granulocytes and marrow granulocyte progenitor cells by PCRbased X-chromosome inactivation analysis of HUMARA gene and the origin of RS cells by iron-staining of erythroid colonies simultaneously in female patients with RARS.
Materials and methods

Patients
Three female patients with RARS were included in this study ( Table 1) . None of the patients had cytotoxic or immunosuppressive treatment prior to the study. They were heterozygous for the number of CAG trinucleotides repeat in the promotor region of HUMARA gene. Their marrow and peripheral blood samples were obtained with informed consent. Four HUM-ARA heterozygotes, whose hematopoiesis was expected to be 131 polyclonal, were also examined as controls after informed consent; two with newly diagnosed idiopathic thrombocytopenic purpura (cases C1 and C2) and the other two with newly diagnosed non-Hodgkin's lymphoma without marrow involvement and showing normal blood cell counts (cases C3 and C4).
Cell preparation
Light density mononuclear cells (MNC) were obtained from marrow and peripheral blood samples by Ficoll-Paque (Pharmacia, Uppsala, Sweden) density gradient centrifugation. Polymorphonuclear cells (PMNCs) were recovered from the peripheral blood erythrocyte pellet by removal of lysed red cells after incubation in Tris·NH 4 Cl buffer. T lymphocytes were separated from peripheral blood MNC by agglutination with sheep red blood cells (Kyokuto, Tokyo, Japan). Purity of the PMNCs and the T lymphocytes was examined by morphology and immunohistochemical CD2 positivity, respectively. The results of three RARS patients were 98, 94, 95% in PMNCs and 98, 90, 91% in T lymphocytes, respectively.
Hematopoietic growth factors and cell culture
Marrow MNC were washed and resuspended in RPMI 1640 (GIBCO, Grand Island, NY, USA) with 20% fetal calf serum (FCS; Boehringer-Mannheim, Mannheim, Germany) at 2 × 10 6 /ml and incubated for 2 h at 37°C in a fully humidified atmosphere of 5% CO 2 then non-adherent cells were collected. Non-adherent marrow MNC were applied for cell culture as previously described 9 except for addition of stem cell factor (SCF) in all culture dishes. Recombinant human granulocyte colony-stimulating factor (G-CSF), erythropoietin (EPO) and SCF were generous gifts from Kirin Brewery (Tokyo, Japan). They were used at a concentration of 100 ng/ml, 4 U/ml and 100 ng/ml, respectively. Recombinant human granulocytes-macrophage colony-stimulating factor (GM-CSF) (100 ng/ml) was a generous gift of Sumitomo Pharmaceutical (Hyogo, Japan).
DNA extraction and processing
Individual granulocyte colonies were randomly picked by hand with a micropipette and immediately placed in 200 l buffer and incubated as previously described. 9 High-molecular weight DNA, extracted from each colony with phenol/chloroform 22 using 20 g of glycogen (Boehringer Mannheim) as a DNA carrier, was equally divided into two aliquots; one was digested by 30 U of HhaI (New England Biolabs, Beverly, MA, USA), a methylation sensitive restriction endonuclease, for more than 6 h at 37°C, and the other was left undigested. Individual BFU-E colonies were also randomly picked and resuspended in 200 l of RPMI 1640 with 10% fetal calf serum. Half of this suspension was used for DNA extraction similar to granulocyte colonies, and the other half served for the morphological examination. Similarly, highmolecular weight DNA of blood PMNCs and T lymphocytes was extracted. In cases 2 and 3, buccal mucosa was scoured off with sterilized swab after informed consent, and DNA was also extracted. Two aliquots containing about 10 ng of DNA were obtained from each sample. One was digested by HhaI under the same conditions as described above. The DNA after HhaI digestion was precipitated in ethanol, and the pellet was then rinsed once with 80% ethanol.
PCR analysis of HUMARA gene
Nested-PCR was introduced into HUMARA clonal assay. DNA from individual colonies and peripheral blood samples both with and without HhaI digestion was added to 50 l of a solution (50 mmol/l KCl, 10 mmol/l TrisHCl (pH 8.3 at 25°C), 1.25 mmol/l MgCl 2 , 250 mol/l dNTPs, bovine serum albumin (BSA) at 170 mg/ml and 3% (v/v) dimethyl sulfoxide (DMSO)) with a set of 'outer' primers, 1A (5′-TAGGTGGAA-GATTCAGCCAAGC-3′) and 1B (5′-TGTGAAGGTTGCTGT-TCCTC-3′), at 1 mmol/l each and 0.5 U of Taq polymerase (Boehringer Mannheim). Samples were amplified for 27 cycles (30 s at 94°C; 30 s at 55°C; 30 s at 72°C). In the second reaction, one-fiftieth of each product was further amplified for 27 cycles in the same solution with a set of 'inner' primers, 2A (5′-TCCAGAATCTGTTCCAGAGC-3′) and 2B (5′-TGGGGA-GAACCATCCTCACC-3′). Following amplification, one-tenth of the product was electrophoresed in a nondenaturing 11% polyacrylamide gel, then stained with ethidium bromide and photographed. For quantifying the upper and lower band intensities, negative films were prepared from the photos and subjected to a densitometer (MasterScan system; CSPI/ Scanalytics, Billerica, MA, USA). 23 The complete digestion with HhaI was confirmed with male DNA simultaneously. Each step of DNA digestion and the amplification was performed under the same conditions as described above. The amplification of DNA digested with HhaI failed (not shown), indicating complete digestion with the enzyme.
Iron staining of erythroid colonies
Cytospin (Shandon Southern Products, Cheshire, UK) preparation was made from half of the individual BFU-E colonies used for the morphological study. The slide was cytocentrifuged at 40 g for 5 min, and performed iron staining according to the method of Perls' reaction for iron. 24 Blue granules or deposits were considered as accumulated iron in the cytoplasm. Erythroblasts with iron granules arranged along more than one-third of the nuclear outline were defined as ringform. Samples with BIR between 25:75 and 75:25 were considered polyclonal, 10 and those showing complete disappearances of either band were taken to be monoclonal. Thus, those with other BIR were considered as skewed inactivation. Bands yielded from the samples of each patient were illus- trated in Figure 2 . PMNCs of all the three patients with RARS showed monoclonal band patterns, whereas those of control individuals were polyclonal in three of four cases (cases C1-C3) and PMNCs of case C4 also showed polyclonal but slightly skewed pattern (26:74). Clonality of T lymphocytes was also examined in all cases. The band pattern was different from that of the PMNCs in two patients who had monoclonal PMNCs (cases 1 and 3) . PMNCs and T lymphocytes of case 2 produced similar band patterns. In cases 2 and 3, whose T lymphocytes showed a monoclonal band pattern, we also confirmed the clonality of buccal cells. The band pattern was consistent with that of T lymphocytes in both cases (Figure 2) . In all four control cases, the band patterns of T lymphocytes were similar to those of PMNCs and in case C4 it was considered as skewed inactivation (23:77).
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Results
Clonality analysis of peripheral blood cells
Clonality analysis of granulocyte progenitor cells
DNA extracted from each colony was effectively amplified even if the colony was composed of less than 100 cells, and no band was observed when amplification was performed without cells (data not shown). The clonal origin of each colony was determined on the basis of the band pattern of amplified DNA with the HhaI treatment. Colonies with the band pattern between 40:60 and 60:40 assessed by BIR were regarded as ambiguous 11 and the others as pattern A (upper band predominance) or pattern B (lower band predominance). DNA predigested with HhaI of some colonies like 'a' and 'b' in Figure 3 yielded a clear single band, so that the clonal origin of the colonies was determined as pattern A or B, respectively. In others, however, one dominant and one minor band were formed (Figure 3c ), on the basis of which we were still capable of identifying the clonal origin. However, 4-22% of colonies showed the ratio of upper to lower band between 40:60 and 60:40 assessed by BIR, and the clonal origin was regarded as ambiguous. The two-band formation may be explained by contamination of nonclonal cells when picking colonies. Since complete digestion with the endonuclease was confirmed using male DNA, and by single upper or lower band formation like 'a' and 'b' colonies as well, it is unlikely that the escape from HhaI digestion caused two bands. The clonal constitution of colonies and BIR of PMNCs of each case was presented in Table 2 . In all cases, even those with PMNCs of monoclonal appearance, colonies with both pattern A and pattern B were identified.
Iron staining and clonality analysis of erythroid progenitors
Single erythroid colony was divided in two and analyzed for morphological features and clonal constitution simultaneously. RS (+) colonies were observed in 18% to 23% of all erythroid colonies. In one RS (+) colony, not all erythroblasts had detectable amounts of iron deposits. The clonal constitutions of erythroid progenitors are shown in Table 2 . In two of three cases, both band pattern A and B were observed, and the distributions of band pattern were similar to those of granuloid progenitors. RS (+) colonies, however, showed only either pattern A or B in every patient, and the pattern was dominant in total erythroid and granuloid colonies in the same patient.
Figure 2
Clonal patterns of peripheral blood cells of all cases by the HUMARA assay. DNA from polymorphonuclear cells (PMN) and T lymphocytes (T cell) was amplified by nested-PCR. DNA in '+' lanes was precut with HhaI. DNA in '−' lanes was left undigested by the enzyme. In cases 2 and 3, X-inactivation patterns of non-hematopoietic (buccal mucosa; Bc) cells were also examined.
Figure 3
X-inactivation patterns of individual granulocyte colonies. Representative pattern observed in case 1 is shown. '+' and '−' denote the DNA with and without the HhaI treatment, respectively. '−' (left) and '+' (right) lanes are a pair, ie the DNA was derived from an individual colony. Notice the '+' lanes. In 'a' and 'b' colonies only one band is visible, while in 'c' one dominant and one minor band were formed. According to these band patterns, the clonal origin of 'a' was determined as pattern A and that of 'b' as pattern B. The pattern like 'c' was included in each major band group. In some colonies, two bands showed similar intensities, so the clonal origin could not be determined (ambiguous, not shown). , the monoclonal band pattern by the lower band. X-inactivation patterns of bone marrow progenitors were expressed as the actual number of colonies showing pattern A or B.
Discussion
In this study, three male patients with RARS were analyzed for their clonality of both peripheral blood cells and bone marrow progenitors. We simultaneously examined the erythroid colony formation in vitro and the clonal constitutions of the erythroid progenitors with their ringed sideroblast formation. Clonality analyses of erythroid colonies positive for iron staining exclusively showed either 'A' or 'B' patterns in all patients. These patterns were consistent with the dominant patterns of granuloid progenitors in their bone marrow as well as the clonal patterns of their peripheral blood PMNCs. The results suggest that ringed sideroblasts (RS) might be derived from the same clonal population as their granuloid progenitors of clonal origin.
The erythroid progenitors lacking iron deposits showed compositions of both 'A' and 'B' patterns in two of the three cases (cases 1 and 2), and the granuloid colonies also showed similar compositions in these cases. These data clearly indicated that the erythroid progenitors in RARS patients also demonstrated the mosaicism of clonal and non-clonal hema-topoiesis as granuloid progenitors. Asano et al 9 previously reported similar results in some refractory anemia (RA) and RA with excess of blasts (RAEB) cases for granuloid and erythroid colonies. The present result confirmed their previous report, and provided further evidence for the existence of non-clonal progenitor cells in some patients with RARS.
Erythroid colonies without RS cells in two of three patients exhibited mosaicism of 'A' and 'B' patterns, and their dominant patterns were quite similar to those of granuloid progenitors. In particular in case 1, the ratio of the 'A' to 'B' pattern was opposite to the BIR of peripheral blood T cells, which might reflect non-clonal hematopoiesis in this patient. These results suggest that clonal hematopoiesis is involved to some extent in RS (−) erythroid progenitors as well as in RS (+) erythroid progenitors.
HUMARA analysis of the clonal nature of T lymphocytes in RARS patients showed deviated methylation patterns in cases 2 and 3. The band pattern was similar to the PMNCs in case 2 and the opposite in case 3. To distinguish between the monoclonal nature of these cells and skewed Lyonization, we simultaneously analyzed DNA from buccal mucosa cells as non-hematological controls. The band pattern was the same as for T lymphocytes and opposite that of the PMNCs in case 3, indicating that the deviated methylation pattern in T lymphocytes reflected skewed Lyonization. In case 2, the band pattern of buccal cells showed the same deviated pattern as in PMNCs and T lymphocytes. Although clonal expansion of T lymphocytes could not be ruled out, the results were consistent with the possible skewed Lyonization in case 2.
In case C4, both PMNCs and T lymphocytes showed slightly skewed Lyonization pattern, so we could not call them polyclonal. Excessive Lyonization has been observed in some hematologically normal females, 25 and case C4 may be considered to be in the same condition.
Our present results clearly indicate that combination of morphological and clonality analyses is a powerful tool for the further understanding of the pathophysiology of MDS. Introduction of other markers combined with morphological and/or progenitor analyses may well provide novel insights for the understanding of clonal hematological disorders.
